Aug 2026· Neuromuscular Disorders· Vol 67, pp.
107399
· 0 citations· 34 references
Medicine
TL;DR
The results highlight the major contribution of a limited number of genes and underscore the importance of early molecular diagnosis in a population with high consanguinity and underscore the importance of early molecular diagnosis in a population with high consanguinity.
Abstract
Congenital myasthenic syndromes (CMS) are inherited disorders caused by defects in proteins essential for neuromuscular transmission. In this nationwide, multicenter retrospective study, we analyzed 133 genetically confirmed CMS cases from 118 unrelated families between 2017 and 2024 across 28 centers in Türkiye. Clinical, electrophysiological, and genetic data were collected from medical records. In addition, we performed a PubMed-based review of previously reported genetically confirmed Turkish CMS cases to place our findings in a broader national context. The median age at symptom onset, and the median diagnostic delay were 6 months and 24 months, respectively. Ocular involvement was the most common clinical feature, followed by respiratory and bulbar involvement. High consanguinity (82%) contributed to a predominance of homozygous variants. Variants were identified in 16 CMS-associated genes, with COLQ (34.6%), CHRNE (24.1%), and CHAT (12.8%) being the most frequent. Postsynaptic CMS was the most common anatomical subgroup. Eighteen novel variants across 11 genes expanded the mutational spectrum of CMS. Review of 23 previously published studies from Türkiye identified 139 additional genetically confirmed cases, showing a broadly similar genetic distribution, with CHRNE and COLQ predominating, followed by CHAT, whereas other CMS-associated genes were reported only sporadically. >These findings define the clinical and genetic landscape of CMS in Türkiye and, together with previously published Turkish cases, provide a broad national overview based on 272 genetically confirmed cases. The results highlight the major contribution of a limited number of genes and underscore the importance of early molecular diagnosis in a population with high consanguinity.
Congenital myasthenic syndromes (CMS) comprise a heterogeneous group of inherited disorders caused by genetic defects affecting neuromuscular junction transmission. Clinical manifestations range from isolated ocular symptoms to severe neonatal respiratory insufficiency. Despite symptom onset early in life, CMS is frequ...
Pelin Yenilmez Yeşildaş, Nevra Öksüz· Neurology Asia· 0 citations
Congenital myasthenic syndromes (CMSs) are a heterogeneous group of genetic neuromuscular disorders caused by pathogenic variants in genes encoding proteins essential for neuromuscular junction development and function. Downstream of tyrosine kinase 7 (DOK7)-related CMS has been reported frequently in Europe, North Ame...
Sangwon Joe, M. Choi, Yunjung Choi et al.· Journal of Electrodiagnosis...· 0 citations
Background. Congenital myasthenic syndrome (CMS) type 11, caused by pathogenic biallelic variants in the RAPSN gene, is one of the most common forms of CMS in patients of European origin. The disease is characterized by significant clinical heterogeneity, which, combined with the variability of electrophysiological fin...
E. Melnik, S. N. Bardakov, S. Nikitin et al.· Neuromuscular Diseases· 0 citations
Abstract Objectives Allgrove syndrome is a rare autosomal recessive disorder caused by pathogenic variants in the AAAS gene, characterized by achalasia, alacrima, and adrenal insufficiency, with variable neurological involvement. Genotype–phenotype correlations remain poorly characterized. This study aimed to describe...
Johana Andrea Botero Hernandez, Eder Donadoni Varela Macias, María Victoria Lopera Cañaveral et al.· Journal of Pediatric Endocri...· 0 citations
This nationwide study expands the genotype-phenotype spectrum of Sotos and Malan syndromes in Türkiye and supports improved diagnostic and clinical management strategies.
Ceren Yılmaz Uzman, Semra Gürsoy, F. Hazan et al.· Clinical Genetics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.